LXRX Q4 2019 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M-48.9% YoY

Gross Profit

$8M91.1% margin

Operating Income

-$47M-541.0% margin

Net Income

-$51M-586.0% margin

EPS (Diluted)

$-0.48

QoQ Revenue Growth

-97.0%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$418M

Total Liabilities

$301M

Stockholders' Equity

$117M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$17M	-48.9%
Gross Profit	$8M	$17M	-51.8%
Operating Income	-$47M	-$12M	-281.8%
Net Income	-$51M	-$17M	-204.7%